Hedyotis diffusa Willd. extract alleviates CCl4-induced liver fibrosis via modulation of the gut microbiota and FXR/SHP/CYP7A1-mediated bile acid metabolism
- 3 March 2026
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 363, 121450
Abstract
No abstract availableKeywords
Funding Information
- Health Commission of Sichuan Province (25LCYJ52)
- Chengdu Medical College (CYZYB25-03)
- Chengdu Medical College (CYZYB24-20)
- Chengdu Medical College (CYFY-GQ77)
- Chengdu Medical College (25LHYW2-03)
- Chengdu Medical College (25LHSFY3-60)
- Sichuan Provincial Science and Technology Support Program (2026NSFSC1849)
This publication has 49 references indexed in Scilit:
- Deacetylasperulosidic Acid Methyl Ester Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis by Suppressing Inflammation and Modulating Gut MicrobiotaInflammation, 2025
- Cytotoxicity of Dysphania botrys L. Extracts Against HEPG2 and SAOS‐2, In Vitro and In SilicoChemistry & Biodiversity, 2025
- Urease inhibitory potency of Chenopodium quinoa seed extract: LC–ESI–MS/MS, GC–MS/MS analysis, biological evaluations, molecular docking, ADMET property, DFT calculation and PASS predictionJournal of Food Measurement and Characterization, 2025
- The immunotherapy mechanism of Hedyotis Diffusae Herba in treating liver cancer: a study based on network pharmacology, bioinformatics, and experimental validationNaunyn-Schmiedeberg's Archives of Pharmacology, 2024
- Phillygenin Ameliorates Carbon Tetrachloride-Induced Liver Fibrosis: Suppression of Inflammation and Wnt/β-Catenin Signaling PathwayInflammation, 2023
- Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorderBiomedicine & Pharmacotherapy, 2022
- Liver biopsy for assessment of chronic liver diseases: a synopsisClinical and Experimental Medicine, 2022
- Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanismsBiomedicine & Pharmacotherapy, 2020
- Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment ModalitiesDrugs, 2019
- Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathyHepatology, 2015